Philip Morris International Inc.
PMI.SW
Swiss Exchange132.00
CHF
-15.00
- -
Philip Morris International Inc.
PMI.SW
(Swiss Exchange)
Recent
price
132.00
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Philip Morris International Inc. is a leading international consumer goods company specializing in the manufacture and sale of tobacco products and smoke-free alternatives. The company's core product portfolio includes combustible cigarettes with flagship brands such as Marlboro; smoke-free products comprising heated tobacco (under the IQOS brand), e-vapor products, oral smokeless tobacco, nicotine pouches (notably the ZYN brand), and snus. PMI operates globally, with presence in over 180 countries. Founded in 1847 and headquartered in Lausanne, Switzerland, the company also has a growing presence in wellness and healthcare sectors through its pharmaceutical and life sciences businesses. Recently, PMI has accelerated its transformation into a smoke-free future, with smoke-free products accounting for approximately 41 percent of global net revenues as of mid-2025, reflecting significant growth in heat-not-burn and oral nicotine product categories. In 2024, PMI launched the IQOS ILUMA i in Japan, featuring advanced induction-heating technology that delivers a more consistent and cleaner experience. The company also extended its long-standing partnership with Scuderia Ferrari HP and the Ferrari Challenge Trofeo Pirelli through 2026, prominently featuring its ZYN brand on Formula 1 car livery. PMI announced a major organizational restructure effective January 2026, creating new U.S. and International Business Units along three reportable segments: International Smoke-Free, International Combustibles, and the U.S. Business Unit, enhancing strategic focus on smoke-free growth while managing combustible products. In 2024 and 2025, PMI continued strategic acquisitions and investments targeted at diversifying beyond tobacco. Notably, in May 2024, PMI acquired a 14.7 percent minority stake in Egypt's Eastern Company to explore collaborative opportunities in technology, manufacturing, and innovation within smoke-free product development. Additionally, PMI divested its inhaled drug delivery specialist Vectura Group in 2024 to refocus its healthcare portfolio amid changing strategic priorities. PMI’s acquisition of Swedish Match in 2022 underpins its leading position in oral nicotine products globally. The company champions tobacco harm reduction through innovative product development, leveraging life sciences expertise to expand into wellness and healthcare. Philip Morris International focuses on adult smokers and nicotine consumers worldwide, aiming by 2030 to have smoke-free products constitute over two-thirds of its net revenues and ultimately phase out cigarettes entirely. Its geographic operations span the Americas, Europe, Asia-Pacific, Middle East, and Africa. The company employs approximately 83,000 people globally and is publicly traded, with shares listed on the New York Stock Exchange and the SIX Swiss Exchange under ticker PMI.SW. This ongoing strategic shift underscores Philip Morris International's commitment to evolving from a traditional tobacco enterprise into a broad-based consumer goods company with a leading smoke-free portfolio and emerging interests in health and wellness sectors.